Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: A clinical trial

Alireza Peyman, Ali Kamali, Maral Khushabi, Kobra Nasrollahi, Neda Kargar, Maryam Taghaodi, Hasan Razmjoo, Farhad Fazel, Asiyeh Salesi, Alireza Peyman, Ali Kamali, Maral Khushabi, Kobra Nasrollahi, Neda Kargar, Maryam Taghaodi, Hasan Razmjoo, Farhad Fazel, Asiyeh Salesi

Abstract

Background: Keratoconus is a bilateral non-inflammatory corneal disease. Collagen cross-linking (CXL) is a new treatment option for the disease that uses ultraviolet A light irradiation and riboflavin administration. The aim of this study is to evaluate the effect of CXL on corneal topographic and refractive values in patients with keratoconus younger than 18 years of age.

Materials and methods: For the clinical trial study, 37 patients (64 eyes) younger than 18 years of age with progressive keratoconus were included. Age, sex, family history of keratoconus, and history of allergic disorders and eye rubbing were recorded. Refractive, topographic, and topometric indices were evaluated before and 12 months after the CXL with 3mW for 30 minutes.

Results: Mean age (±SD) of the patients was 15.83 ± 1.53 years; 26 (70.3%) of the 37 patients were male. Fourteen (37.8%) had positive family history of keratoconus, 11 (29.7%) had history of allergic disorders, and 15 (40.5%) had positive history of eye rubbing. Of the refractive values, cylinder value decreased significantly from -4.50 ± 0.29 to -4.11 ± 0.28 (P = 0.001). Also, the logarithm of minimal angle of resolution (logMAR) uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) improved significantly 12 months after CXL (P = 0.012 and 0.001, respectively). Maximum keratometry before and after the operation was 53.82 ± 0.72 and 53.33 ± 0.72, respectively (P = 0.018). Differences for simulated K values, the thinnest cornea pachymetry, keratoconus index (KI), index of highest asymmetry (IHA), and index of highest decentration (IHD) before and 12 months after the CXL were statistically significant (P = 0.015, 0.034, <0.001, 0.017, 0.019, and 0.004, respectively).

Conclusion: CXL improves the refractory, topographic, and topometric indices in patients with keratoconus younger than 18 years of age.

Keywords: Collagen cross-linking; progressive keratoconus; refractive value; topography.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.
    1. Kim H, Joo CK. Measure of keratoconus progression using Orbscan II. J Refract Surg. 2008;24:600–5.
    1. Bechrakis N, Blom ML, Stark WJ, Green WR. Recurrent keratoconus. Cornea. 1994;13:73–7.
    1. Pantanelli S, MacRae S, Jeong TM, Yoon G. Characterizing the wave aberration in eyes with keratoconus or penetrating keratoplasty using a high-dynamic range wavefront sensor. Ophthalmology. 2007;114:2013–21.
    1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322.
    1. Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994;101:439–47.
    1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–7.
    1. Arbelaez MC, Sekito MB, Vidal C, Choudhury SR. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: One-year results. Oman J Ophthalmol. 2009;2:33–8.
    1. Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE. Biomechanical evidence of the distribution of cross-links in corneastreated with riboflavin and ultraviolet A light. J Cataract Refract Surg. 2006;32:279–83.
    1. Razmjoo H, Nasrollahi AP, Salam H, Karbasi N, Najarzadegan MR. Topographic corneal changes after collagen cross-linking in patients with corneal keratoconus. J Res Med Sci. 2013;18:882–6.
    1. Suzuki M, Amano S, Honda N, Usui T, Yamagami S, Oshika T. Longitudinal changes in corneal irregular astigmatism and visual acuity in eyes with keratoconus. Jpn J Ophthalmol. 2007;51:265–9.
    1. Saini JS, Saroha V, Singh P, Sukhija JS, Jain AK. Keratoconus in Asian eyes at a tertiary eye care facility. Clin Exp Optom. 2004;87:97–101.
    1. Zadnik K, Barr JT, Edrington TB, Everett DF, Jameson M, McMahon TT, et al. Baseline findings in the collaborative longitudinal evaluation of keratoconus (CLEK) study. Invest Ophthalmol Vis Sci. 1998;39:2537–46.
    1. Gonzalez V, McDonnell PJ. Computer-assisted corneal topography in parents of patients with keratoconus. Arch Ophthalmol. 1992;110:1413–4.
    1. Davies PD, Lobascher D, Menon JA, Rahi AH, Ruben M. Immunological studies in keratoconus. Trans Ophthalmol Soc U K. 1976;96:173–8.
    1. Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol. 1977;61:761–4.
    1. Copeman PW. Eczema and keratoconus. Br Med J. 1965;2:977–9.
    1. Karseras AG, Ruben M. Aetiology of keratoconus. Br J Ophthalmol. 1976;60:522–5.
    1. Saffarian L, Khakshoor H, Zarei-Ghanavati M, Esmaily H. Corneal crosslinking for keratoconus in iranian patients: Outcomes at 1 year following treatment. Middle East Afr J Ophthalmol. 2010;17:365–8.
    1. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term results. J Cataract Refract Surg. 2008;34:796–801.
    1. Hoyer A, Raiskup-Wolf F, Spörl E, Pillunat LE. Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from Dresden. Ophthalmologe. 2009;106:133–40.
    1. Agrawal VB. Corneal collagen cross-linking with riboflavin and ultraviolet - A light for keratoconus: Results in Indian eyes. Indian J Ophthalmol. 2009;57:111–4.
    1. Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: Preliminary results. J Refract Surg. 2008;24:S720–5.
    1. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: The Siena eye cross study. Am J Ophthalmol. 2010;149:585–93.
    1. Wollensak G, Spörl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe. 2003;100:44–9.
    1. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease - A review. Clin Experiment Ophthalmol. 2010;38:141–53.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅